Literature DB >> 23396732

Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study.

Hossein Keyvani1, Shahram Agah, Ali Kabir, Seyed Moayed Alavian.   

Abstract

BACKGROUND: Recent studies have demonstrated that prevention of hepatitis B virus (HBV) transmission remains a challenge in hemodialysis (HD) patients. The aim of this study is to explore factors which increase the possibility of occult HBV (OHB) infection in patients under HD in Iran.
MATERIAL AND METHODS: Among 2188 cases who spent an average of 60.2 ± 61.1 months under HD, we selected 103 cases with isolated antihepatitis B virus core antibody (anti-HBc) and 231 controls without any HBV, hepatitis D virus (HDV) and hepatitis C virus (HCV) serologic markers. Socio-demographic data, past medical history, and clinical signs and symptoms were assessed.
RESULTS: The frequency of checking hepatitis B serologic markers was 15.3%. The rate of OHB infection in HD patients who were monitored for their HBV markers was 4.9%. Cases with isolated anti-HBc had significantly higher percentage of positive HBV DNA [odds ratio: OR (95% confidence interval: 95% CI) = 12.1 (1.4-105)], visual disturbances [OR (95% CI) = 1.8 (1.1-3.03)], history of diabetes mellitus [OR (95% CI) = 2.1 (1.3-3.5)], higher age, higher age when dialysis started and were mostly married, illiterate, disabled and retired. Diabetes mellitus was the only independent predictor of HBV DNA status in cases with isolated anti-HBc.
CONCLUSION: In our region, OHB infection is prevalent among hemodialysis patients and displays a direct correlation with factors which are age related except diabetes mellitus. Thus, the presence of isolated anti-HBc should prompt the clinician to evaluate a possible OHB infection especially when it is detected in conjunction with a history of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396732

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  10 in total

Review 1.  Management of patients with hepatitis B in special populations.

Authors:  Evangelos Cholongitas; Konstantinos Tziomalos; Chrysoula Pipili
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

2.  Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis.

Authors:  Cuixia Cai; Jun Zeng; Huihui Wu; Rong Shi; Min Wei; Yuan Gao; Wenli Ma
Journal:  Exp Ther Med       Date:  2015-06-03       Impact factor: 2.447

3.  Serum hyaluronic acid in chronic viral hepatitis B and C: a biomarker for assessing liver fibrosis in chronic hemodialysis patients.

Authors:  Olga Hilda Orăşan; Mădălina Sava; Mihaela Iancu; Angela Cozma; Aniela Saplonţai-Pop; Simina Sarlea Ţărmure; Corneliu Lungoci; Remus Aurel Orăşan; Ioan Mihai Patiu; Dan Lucian Dumitraşcu
Journal:  Int Urol Nephrol       Date:  2015-05-30       Impact factor: 2.370

4.  The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons.

Authors:  Kiana Shirani; Zary Nokhodian; Nazila Kassaian; Peyman Adibi; Alireza Emami Naeini; Behrooz Ataei
Journal:  Adv Biomed Res       Date:  2015-01-30

5.  Oncogenic Viral Infections Among Iranian Hemodialysis Patients: A Systematic Review.

Authors:  Nahid Ramezan Ghorbani; Mostafa Qorbani; Shirin Djalalinia; Mehrdad Kazemzadeh Atoofi; Ramin Tajbakhsh; Morteza Mansourian; Armita Mahdavi Gorabi; Hamid Asayesh; Ali Soleimani; Mehdi Noroozi
Journal:  Int J Prev Med       Date:  2019-12-10

6.  Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil.

Authors:  Alcionede de Oliveira dos Santos; Luan Felipo Botelho Souza; Lourdes Maria Borzacov; Juan Miguel Villalobos-Salcedo; Deusilene Souza Vieira
Journal:  Virol J       Date:  2014-01-28       Impact factor: 4.099

7.  Occult hepatitis B virus among the patients with abnormal alanine transaminase.

Authors:  Manoochehr Makvandi; Niloofar Neisi; Davod Khalafkhany; Kamyar Makvandi; Eskandar Hajiani; Ali Akbar Shayesteh; Abdolrahim Masjedi Zadeh; Amir Hosein Sina; Mojtaba Hamidifard; Mojtaba Rasti; Ehsan Aryan; Kambiz Ahmadi; Mohammad Jafar Yad Yad
Journal:  Jundishapur J Microbiol       Date:  2014-07-13       Impact factor: 0.747

Review 8.  Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis.

Authors:  Mostafa Salehi-Vaziri; Farzin Sadeghi; Amir Almasi Hashiani; Mohammad Gholami Fesharaki; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-04-26       Impact factor: 0.660

9.  Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection.

Authors:  Nasrin Rastegarvand; Manoochehr Makvandi; Alireza Samarbafzadeh; Mojtaba Rasti; Niloofar Neisi; Amir Pouremamali; Ali Teimoori; Abdolnabi Shabani
Journal:  Jundishapur J Microbiol       Date:  2015-10-26       Impact factor: 0.747

10.  The Guerilla Tactics of Hepatitis B Virus in Hemodialysis: Fighting a Stubborn Foe.

Authors:  Leslie P Wong
Journal:  Kidney Med       Date:  2019-10-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.